Radiation Safety Training Educator
Tina is a Radiation Safety Training Educator within Radiation Services. She is responsible for the development, maintenance, and delivery of radiation safety courses to different facets of industry.
Showing 621 - 640 of 1397 results
Japanese press release featuring work done at OPAL
ANSTO's National Science Week events
National Science Week is a time to celebrate science and the important role national science agencies like ANSTO play in delivering outcomes that benefit all Australians.
Clarity Pharmaceuticals raises $1.1 million
Peak Resources commissions ANSTO Minerals to operate Ngualla Rare Earths Pilot Plant
As a result of the successful optimisation testwork, Peak Resources has commissioned ANSTO Minerals to operate the pilot plant to validate the optimised “Alkali Roast” process flowsheet that has been selected by Peak for the Bankable Feasibility Study. The study is expected to be completed by early 2017.
ANSTO is helping construct Australia’s first dark matter lab
Launch of the second phase of construction of the underground laboratory to detect dark matter.
The impact of copper on a native fish
Copper (Cu) is a harmful contaminant in freshwater systems, the concentration of which is being increased by human activity. The impact of elevated copper on fish, particularly during the larval development stage, is not well understood.
Instrument Scientist
Role at ANSTO
ANSTO welcomes appointment of CEO for the Australian radioactive waste agency
ANSTO welcomes the recent announcement that the inaugural CEO for the Australian Radioactive Waste Agency (ARWA) has been appointed, following a global search. Mr Sam Usher will lead ARWA and comes to the role with almost three decades of experience in the nuclear industry.
ANSTO facilities and expertise supply a large range of radioisotopes for radiopharmaceutical and environmental applications
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
Agreement bolsters nuclear science education in South Korea
Sustainability expert joins ANSTO's Innovation Precinct
Dr Anne Hellstedt has been appointed Director of ANSTO’s Innovation Precinct.
Grant Success
Both the Australian Centre for Neutron Scattering and the National Deuteration Facility share in grants
Successful clinical trial for prostate cancer enabled by ANSTO
The new targeted treatment for aggressive prostate cancer, which include lutetium produced at ANSTO, has shown to produce more potent and durable responses in men and with fewer side-effects.
Year 9-10 Introduction to Nuclear Science
This tour is an introduction to isotopes, radioactivity and half-life, and the real-life applications of these concepts. Students will do a series of hands-on activities using the workbook below. Please ensure that you bring printed copies of the workbook for the students to use while completing these activities.
We are working on new content to address the new 2026 NSW Science Stage 5 (Year 9-10) syllabus.
All tours are available Monday to Friday for Years 7 to 12 classes. The cost per student is $12.50 and teachers are free.
Teachers are requested to print enough copies of the relevant workbook for their class before their visit to ANSTO, as students will not be permitted to bring digital devices on-site.
Nuclear Medicine
Faisal studied Electrical engineering at the University of Queensland and started their career in a role that specialised in integration of control systems in factories, large-scale rock crushing machinery, and marine luxury yachts.
Federal grants for ANSTO expertise and infrastructure will benefit manufacturing and nuclear technologies
Three new federal grants were announced to support manufacturing and nuclear technologies.
ANSTO scientists share thoughts on Oppenheimer film
Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.